Application of spina gleditsiae to preparation of antioxidant or nitric oxide release inhibitor
An anti-oxidant and nitric oxide technology, applied in anti-toxic, anti-inflammatory, anti-infective, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] The present embodiment measures DPPH free radical scavenging activity by the following method
[0035] (1) Preparation of DPPH solution and test solution
[0036] DPPH · Make 2×10 with absolute ethanol -4 The solution of M was stored at 4°C in the dark. Each monomeric compound and positive drug was made into 1 mg / mL stock solution with absolute ethanol, and diluted with absolute ethanol to the required concentration before testing.
[0037] (2) Determination of activity
[0038] Referring to the experimental method in the literature and improving it, 100 μL of different concentrations of the test solution and 2 × 10 -4 Add 100 μL of MDPPH solution to each well of a 96-well plate, and simultaneously use the concentrations of the test solution without adding DPPH (100 μL absolute ethanol instead of DPPH) as a control to eliminate the interference of the color of the test product itself on the test results. A DPPH·negative control was also set up (100 μL absolute ethanol...
Embodiment 2
[0048] The present embodiment measures the oxygen free radical scavenging capacity by the following method
[0049] (1) preparation of reaction reagent and need testing solution
[0050] Fluorescein disodium with 75mM potassium phosphate buffer (75mM KH 2 PO 4 , 75mM K 2 HPO 4 ) to prepare a 63 μM stock solution, store at 4°C in the dark, and dilute 100 times with this buffer solution before testing. AAPH was made into 18.3mM solution with 75mM potassium phosphate buffer before the experiment. Trolox was formulated with 75mM potassium phosphate buffer solution to make a 10μM stock solution, which was diluted to the required concentration before testing. Each monomeric compound and the positive drug VC were made into a 100 mM stock solution with 75 mM potassium phosphate buffer solution, and diluted to the required concentration with the buffer solution before testing.
[0051] (2) Determination of activity
[0052] The ORAC determination used in this experiment refers t...
Embodiment 3
[0059] In this embodiment, the activity of inhibiting rat macrophage NO release was measured by the following method
[0060] Since NO is extremely unstable, it is quickly oxidized to Stable in nature, it can be determined by Indirectly reflect the production of NO. In this paper, the Griess method was used to determine the content, the principle is that under acidic conditions, Diazotization with p-aminobenzenesulfonamide (Sulfanilamide), and then coupling reaction with N-1-naphthylene-diamine dihydrochloride (N-1-naphthylene-diamine dihydrochloride) to generate a purple azo dye, which is in There is a maximum absorption spectrum at 570nm, and its absorbance can be measured with an enzyme-linked immunosorbent assay. Determination by Griess method With the characteristics of high sensitivity, high accuracy and reproducibility, and the method is simple and effective, it is currently the most commonly used assay content, and methods of measuring NO levels.
[0061] ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com